Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 150
Filter
1.
Dermatologie (Heidelb) ; 73(12): 959-964, 2022 Dec.
Article in German | MEDLINE | ID: mdl-35925211

ABSTRACT

Severe, blistering, adverse drug reactions involving the skin include Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Allopurinol, anticonvulsants, sulphonamide antibiotics and non-steroidal anti-inflammatory drugs in the oxicam class have been repeatedly described as triggers. Increasingly, immunotherapies are also coming into focus as triggers of severe skin reactions. Two patients with bullous skin symptoms after administration of the checkpoint inhibitor pembrolizumab are presented. As the clinical picture does not always allow an unequivocal classification, a histological assessment is often indispensable.


Subject(s)
Stevens-Johnson Syndrome , Humans , Stevens-Johnson Syndrome/diagnosis , Allopurinol/adverse effects , Antibodies, Monoclonal, Humanized/adverse effects , Skin/pathology
2.
Hautarzt ; 71(3): 190-196, 2020 Mar.
Article in German | MEDLINE | ID: mdl-31792581

ABSTRACT

BACKGROUND: Preservatives in cosmetics are often suspected as contact sensitizers and hence frequently patch tested in dermatitis patients. Exposure in this field has changed over the course of years. OBJECTIVE: To describe the frequency of contact sensitization to various preservatives. MATERIALS AND METHODS: Retrospective data analysis from the Information Network of Departments of Dermatology (IVDK) for the years 2009-2018. RESULTS: Frequency of sensitization to methylisothiazolinone (MI) has increased from 2.0% in 2009 to 7.2% in 2013. Since 2014, the rate has been falling again. Increasing the patch test concentration of methyldibromo glutaronitrile (MDBGN) in 2016 has caused a sudden rise in positive patch test reactions from 2.0% to more than 4.5%. Allergic reactions to other preservatives occurred in less than 1% of the patients tested. DISCUSSION: Since 2014, the worldwide "epidemic" of sensitization to MI has been subsiding in Central Europe, thanks to corresponding restrictions on use. Since 2008, there is no longer any widespread exposure to MDBGN; the new, higher test concentration elicits many false-positive test reactions and explains the sudden rise in positive patch test reactions since 2016. Despite widespread use, phenoxyethanol, benzoates, benzyl alcohol, parabens and sorbates rarely cause allergic reactions. Therefore, they can be recommended for cosmetics from the epidemiological-allergological point of view.


Subject(s)
Allergens/adverse effects , Cosmetics/adverse effects , Dermatitis, Allergic Contact/diagnosis , Patch Tests/methods , Preservatives, Pharmaceutical/adverse effects , Dermatitis, Allergic Contact/etiology , Europe , Humans , Nitriles , Predictive Value of Tests , Retrospective Studies , Thiazoles
5.
Hautarzt ; 69(10): 857-869, 2018 Oct.
Article in German | MEDLINE | ID: mdl-30218113

ABSTRACT

Although primary hyperhidrosis is a common disease, secondary symptomatic hyperhidrosis is rather rare. Primary hyperhidrosis is a complex neuropathic dysregulation with a genetic predisposition and is diagnosed when patients show pathologic sweating patterns and excessive sweating for at least 6 months and fulfill at least four of the following criteria: affected areas are axillae and/or palms and/or soles and/or forehead; symmetry; no night sweating; at least once a week; onset before the age of 25; positive family history; negative impact on daily activities. Frequently used therapies are topical aluminum salts and anticholinergics, iontophoresis in water, and intracutaneous botulinum toxin. Anticholinergics are also used as systemic treatment. Surgical procedures are used as a last result. Furthermore procedures using thermolysis have been developed.


Subject(s)
Hyperhidrosis , Aluminum Compounds , Axilla , Botulinum Toxins, Type A , Humans , Hyperhidrosis/diagnosis , Hyperhidrosis/drug therapy , Hyperhidrosis/etiology , Iontophoresis
6.
Allergy ; 73(1): 93-105, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28670695

ABSTRACT

BACKGROUND: Glycoproteins and glycolipids of some mammalian species contain the disaccharide galactosyl-α-(1,3)-galactose (α-Gal). It is known that α-Gal is immunogenic in humans and causes glycan-specific IgG and also IgE responses with clinical relevance. α-Gal is part of the IgE-reactive monoclonal therapeutic antibody cetuximab (CTX) and is associated with delayed anaphylaxis to red meat. In this study, different α-Gal-containing analytes are examined in singleplex and multiplex assays to resolve individual sensitization patterns with IgE against α-Gal. METHODS: Three serum groups, α-Gal-associated meat allergy (MA) patients, idiopathic anaphylaxis (IA) patients with suspected MA, and non-meat-allergic healthy control individuals (HC), were analyzed via singleplex allergy diagnostics and a newly established immunoblot diagnostic system. The new dot blot detection system resolved individual IgE sensitization profiles for α-Gal-containing analytes CTX, bovine thyroglobulin (Bos d TG), and human serum albumin (HSA)-conjugated α-Gal. RESULTS: Singleplex allergy diagnostics using the α-Gal analytes CTX and Bos d TG confirms the history of MA patients in 91% and 88% of the cases, respectively. A novel dot blot-based assay system for the detection of IgE against α-Gal reveals individual IgE sensitization profiles for α-Gal-containing analytes. An α-Gal-associated IgE cross-reactivity profile (IgE against CTX, Bos d TG, and HSA-α-Gal) was identified, which is associated with MA. CONCLUSIONS: Detection of individual sensitization patterns with different α-Gal-containing analytes provides the basis for an individual allergy diagnosis for α-Gal-sensitized patients. Higher amounts of α-Gal in pork and beef innards compared to muscle meat as indicated by a higher staining intensity are a plausible explanation for the difference in allergic symptom severity.


Subject(s)
Allergens/immunology , Food Hypersensitivity/diagnosis , Food Hypersensitivity/immunology , Galactose/immunology , Immunoglobulin E/immunology , Meat/adverse effects , Adult , Aged , Anaphylaxis/diagnosis , Anaphylaxis/immunology , Case-Control Studies , Cross Reactions/immunology , Female , Galactose/chemistry , Humans , Immunochemistry , Male , Middle Aged , Red Meat/adverse effects , Young Adult
7.
Allergol Select ; 1(1): 21-27, 2017.
Article in English | MEDLINE | ID: mdl-30402598

ABSTRACT

Food allergens are frequent causes of anaphylaxis. In particular in children and adolescents they are the most frequent elicitors of severe allergic reactions, and in adults food allergens rank third behind insect venom and drugs. Since July 2006 severe allergic reactions from Germany, Austria, and Switzerland are collected in the anaphylaxis registry. Currently 78 hospitals and private practises are connected. From July 2006 until February 2009 1,156 severe allergic reactions were registered. Among children and adolescents (n = 187, age range from 3 months to 17 years) food allergens were the most frequent triggers, comprising 58% of cases. In the adult group (n = 968, 18 - 85 years) food allergens were in the third position (16.3%) behind insect venom and drugs. In children legumes (31%) and in particular peanuts were frequently responsible food allergens, followed by tree nuts (25%) with hazelnut being the most frequent elicitor. In adults fruits (13.4%) most often induced severe food-dependent anaphylaxis, but also animal products (12.2%); among these most frequently crustaceans and molluscs. Cofactors were often suspected in food-dependent anaphylaxis, namely in 39% of the adult group and in 14% of the pediatric group. In adults drugs (22%) and physical activity (10%) were reported to be the most frequent cofactors, in children physical activity was suspected in 8.7% and drugs in 2.6%. Concomitant diseases like atopic dermatitis, allergic asthma, or allergic rhinoconjunctivitis were reported in 78% of children and adolescents and in 67% of the adults. In conclusion, food-induced anaphylaxis, its cofactors and concomitant diseases are age-dependent. The data offers to identify risk factors of anaphylaxis.

8.
Hautarzt ; 67(5): 352-8, 2016 May.
Article in German | MEDLINE | ID: mdl-26943358

ABSTRACT

Nowadays, for modern electrotherapy of cardiac arrhythmias different pacemaker systems are used. Antibradycardia pacing systems (e. g. single-chamber, two-chamber, three-chamber systems, frequency-adapted pacemaker) can be distinguished from antitachycardia pacing systems like implantable or portable cardioverter defibrillators and combined antibradycardia/antitachycardia systems. Cutaneous reactions overlying a pacemaker or defibrillator are often termed "pacemaker dermatitis". In terms of the differential diagnostic workup, these cutaneous reactions can have various causes. After exclusion of infection by analyzing clinical and laboratory-chemical results, "pressure dermatitis" or the often clinically asymptomatic "reticular telangiectatic erythema" (synonym "postimplantation erythema") must be considered. Histological examination of the affected skin can contribute to the diagnosis. In case of suspected contact hypersensitivity to implant material, allergological exploration should be realized. In addition to patch testing with commercially available contact allergens, product-related material metal alloy discs are often available from the pacemaker manufacturer for epicutaneous testing. Due to the lack of additional benefit compared to standardized patch testing, a clear recommendation for such metal alloy discs cannot be given. In selected cases of suspected hypersensitivity reaction, sensitization can eventually be analyzed by the lymphocyte transformation test. Positive reactions must always be critically interpreted taking into consideration the corresponding clinical signs. Depending on the cause, cutaneous reactions are occasionally self-limiting. In many cases, however, removal of the pacemaker is inevitable.


Subject(s)
Defibrillators, Implantable/adverse effects , Dermatitis, Contact/diagnosis , Dermatitis, Contact/etiology , Metals/adverse effects , Pacemaker, Artificial/adverse effects , Patch Tests/methods , Dermatitis, Contact/prevention & control , Humans
9.
Orthopade ; 44(11): 905-8, 2015 Nov.
Article in German | MEDLINE | ID: mdl-26438196

ABSTRACT

Intolerance reactions to metal implants may be caused by metal allergy. However, prior to implantation, patch testing should not be done in a prophylactic-prophetic approach. Pre-implant patch testing should only be performed to verify or exclude metal allergy in patients with a reported respective history. In the case of implant-in particular arthroplasty-related complications like, for example, pain, effusion, skin changes, reduced range of motion, or loosening, orthopedic-surgical differential diagnostics should be performed first. Allergological workup of suspected metal implant allergy should be done with the DKG baseline series which contains nickel-, cobalt- and chromium-preparations. Various studies assessing the usefulness of metal alloy discs for patch testing proved that this approach does not give reliable information about metal allergy. Positive patch test reactions to the discs cannot be assigned to a specific metal within the disc alloy components. Furthermore, availability of such metal discs might be an invitation to uncritical testing. Accordingly, due to lack of benefit in comparison to patch testing with standardized metal salt preparations, we do not recommend patch testing with metal alloy discs.


Subject(s)
Alloys/adverse effects , Dermatitis, Contact/diagnosis , Metals/adverse effects , Patch Tests/instrumentation , Prostheses and Implants/adverse effects , Dermatitis, Contact/etiology , Equipment Design , Equipment Failure Analysis/methods , Humans , Materials Testing/methods , Patch Tests/methods , Reproducibility of Results , Sensitivity and Specificity
10.
Eur J Nucl Med Mol Imaging ; 41(1): 59-67, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23974666

ABSTRACT

PURPOSE: This study was designed to assess the additional value of SPECT/CT of the trunk used in conjunction with conventional nuclear imaging and its effects on patient management in a large patient series. METHODS: In 353 patients, whole-body scintigraphy (WBS), SPECT, and SPECT/CT were prospectively performed for staging and restaging. SPECT/CT of the trunk was performed in all patients. In the 308 evaluable patients (211 with breast cancer, 97 with prostate cancer), clinical follow-up was used as the gold standard. Bone metastases were confirmed in 72 patients and excluded in 236. Multistep analyses per lesion and per patient were performed. Clinical relevance was expressed in terms of downstaging and upstaging rates on a per-patient basis. RESULTS: In the total patient group, sensitivities, specificities, and negative and positive predictive values on a per-patient basis were 93 %, 78 %, 95 % and 59 % for WBS, 94 %, 71 %, 97 % and 53 % for SPECT, and 97 %, 94 %, 97 % and 88 % for SPECT/CT, respectively. In all subgroups, specificity and positive predictive value were significantly (p<0.01) better with SPECT/CT. Downstaging of metastatic disease in the total, breast cancer and prostate cancer groups using SPECT/CT was possible in 32.1 %, 33.8 % and 29.5 % of patients, respectively. Upstaging in previously negative patients by additional SPECT/CT was observed in three breast cancer patients (2.1 %). Further diagnostic imaging procedures for unclear scintigraphic findings were necessary in only 2.5 % of patients. SPECT/CT improved diagnostic accuracy for defining the extent of multifocal metastatic disease in 34.6 % of these patients. CONCLUSIONS: SPECT/CT significantly improved the specificity and positive predictive value of bone scintigraphy in cancer patients. In breast cancer patients, we found a slight increase in sensitivity. SPECT/CT had a significant effect on clinical management because of correct downstaging and upstaging, better definition of the extent of metastases, and a reduction in further diagnostic procedures.


Subject(s)
Bone Neoplasms/secondary , Bone and Bones/diagnostic imaging , Multimodal Imaging , Tomography, Emission-Computed, Single-Photon , Tomography, X-Ray Computed , Whole Body Imaging , Bone Neoplasms/diagnostic imaging , Female , Humans , Male , Middle Aged , ROC Curve
11.
Hautarzt ; 65(2): 130-2, 2014 Feb.
Article in German | MEDLINE | ID: mdl-24141429

ABSTRACT

A 38-year-old woman presented with recurrent episodes of urticaria after contact with water affecting the upper part of the body. We confirmed the diagnosis of aquagenic urticaria. Aquagenic urticaria is a rare form of contact urticaria with small wheals generally affecting the upper part of the body. It has to be distinguished from aquagenic pruritus. The pathogenetic mechanisms are not known in detail. Treatment with antihistamines, ultraviolet therapy or application of protective hydrophobic barrier creams could be effective.


Subject(s)
Bandages , Cetirizine/administration & dosage , Urticaria/diagnosis , Urticaria/therapy , Adult , Anti-Allergic Agents/administration & dosage , Diagnosis, Differential , Female , Histamine Antagonists/administration & dosage , Humans , Treatment Outcome , Chronic Inducible Urticaria
12.
Expert Opin Drug Deliv ; 8(7): 939-48, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21506903

ABSTRACT

INTRODUCTION: Transdermal patch systems are an effective method of administering active ingredients through the skin, with considerable advantages over other drug delivery routes, for example, maintenance of constant plasma drug levels and avoidance of first-pass metabolism. However, repeated epicutaneous application may be associated with local skin reactions. AREAS COVERED: This review addresses current issues regarding the effective/safe use of transdermal patch systems, and provides a critical analysis of the addition of 'skin-caring' ingredients to patch systems. Effective use of transdermal systems includes choosing an appropriate body area for application, maintaining regular skin care regimens before application and not replacing a patch in the same area (rotation) within 7 days. Another strategy, developed in an attempt to improve the tolerability of transdermal systems, is the addition of assumed 'skin-caring' ingredients (e.g., Aloe Vera) to patch systems. However, at present there is neither proof nor clinical evidence of any benefit. On the contrary, plant-derived ingredients might be associated with allergenic potential. EXPERT OPINION: Transdermal systems are generally well tolerated; physicians must adequately inform patients of the most effective ways to use these formulations for maximum therapeutic benefit, while minimising local adverse events. Skin-caring agents, including Aloe Vera, cannot be recommended until well-controlled clinical trials with standardised extracts are available.


Subject(s)
Administration, Cutaneous , Drug-Related Side Effects and Adverse Reactions , Skin/drug effects , Humans , Pharmaceutical Preparations/administration & dosage
13.
Internist (Berl) ; 51(8): 1050-2, 2010 Aug.
Article in German | MEDLINE | ID: mdl-20437163

ABSTRACT

A 37-year-old homosexual man was admitted because of oropharyngeal pain, fever, diarrhea, loss of weight and lymphadenopathy since one week. Acute retroviral syndrome (ARS) in primary HIV type 1 infection was diagnosed, associated with Giardia lamblia infection. Antiinfective and combined antiretroviral treatment was established, and the general condition of the patient rapidly improved. The presented report demonstrates that in case of acute HIV-infection with diarrhea other infections should be considered, particularly with regard to enteropathogens like Giardia lamblia.


Subject(s)
AIDS-Related Opportunistic Infections/diagnosis , Diarrhea/etiology , Fever of Unknown Origin/etiology , Giardia lamblia , Giardiasis/diagnosis , HIV Seropositivity/diagnosis , HIV-1 , Homosexuality, Male , Lymphatic Diseases/etiology , AIDS Serodiagnosis , AIDS-Related Opportunistic Infections/drug therapy , Adult , Anti-Bacterial Agents/therapeutic use , Antifungal Agents/therapeutic use , Antiretroviral Therapy, Highly Active , Candidiasis, Oral/diagnosis , Candidiasis, Oral/drug therapy , Ciprofloxacin/therapeutic use , Clarithromycin/therapeutic use , Diagnosis, Differential , Drug Therapy, Combination , Fluconazole/therapeutic use , Giardiasis/drug therapy , Humans , Immunoblotting , Male , Metronidazole/therapeutic use , Omeprazole/therapeutic use
15.
Skin Pharmacol Physiol ; 23(4): 177-82, 2010.
Article in English | MEDLINE | ID: mdl-20185975

ABSTRACT

The evaluation of the benefit/risk ratio (BRR) for topical glucocorticoids (TGC) allows the comparison of active ingredients and thereby includes aspects of dosage (blanching response, BR) as well as adverse effects (skin atrophy). In the present study, the BRR of hydrocortisone aceponate, prednicarbate and betamethasone valerate was investigated according to an adapted procedure for investigating the BR. The main difference is the longer application period of the investigational substance without occlusion. Thus, the pharmacokinetic characteristics of all of the systems are considered more intensely and the penetration conditions are designed in a realistic way, namely oriented towards the preparation in order to improve the significance and relevance of the BRR for practical use. The results demonstrate that the investigated substances also show differences in the extent of the BR, but on the other hand they show that the improved penetration characteristics of the double-esterified compounds are clearly less effective. In comparison to the BRR, this results to a large extent in a balanced picture without relevant advantages for single preparations. Nevertheless, the already mentioned positive characteristics of the investigated TGC and the positive practical clinical experiences have been approved. Further investigations have to show whether the method presented here for investigating the BR offers advantages in the comparative assessment of TGC.


Subject(s)
Glucocorticoids/administration & dosage , Glucocorticoids/metabolism , Hydrocortisone/analogs & derivatives , Skin Absorption/drug effects , Skin Absorption/physiology , Administration, Topical , Adult , Double-Blind Method , Female , Follow-Up Studies , Glucocorticoids/therapeutic use , Humans , Hydrocortisone/administration & dosage , Hydrocortisone/metabolism , Hydrocortisone/therapeutic use , Male , Middle Aged , Reference Standards , Risk Factors , Young Adult
17.
Rev Med Liege ; 64(1): 41-4, 2009 Jan.
Article in French | MEDLINE | ID: mdl-19317101

ABSTRACT

Endometriosis is defined as the presence of endometrial tissue outside the uterine cavity. Involvement of the umbilical region is rare. We present the case of a woman with ovarian endometriosis associated with extragenital umbilical endometriosis. The umbilical lesion was completely removed. We take the opportunity of this case to give a short survey with consideration to histopathological and therapeutic aspects as well as possible differential diagnostics.


Subject(s)
Endometriosis/diagnosis , Ovarian Diseases/diagnosis , Umbilicus/pathology , Adult , Diagnosis, Differential , Endometriosis/pathology , Endometriosis/surgery , Female , Humans , Ovarian Diseases/pathology , Ovarian Diseases/surgery , Treatment Outcome , Umbilicus/surgery
18.
Hautarzt ; 60(5): 424-7, 2009 May.
Article in German | MEDLINE | ID: mdl-19093092

ABSTRACT

We report on a case of a bufexamac-induced allergic contact dermatitis with hematogenous dissemination presenting with the clinical and histological picture of a pigmented purpuric eruption. To our knowledge this is the first report on a bufexamac-induced pigmented purpuric dermatosis. It represents a further example of the clinical variety of cutaneous side-effects caused by bufexamac.


Subject(s)
Bufexamac/adverse effects , Drug Eruptions/diagnosis , Drug Eruptions/etiology , Pigmentation Disorders/chemically induced , Pigmentation Disorders/diagnosis , Purpura/chemically induced , Purpura/diagnosis , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Humans , Male , Middle Aged , Pigmentation Disorders/prevention & control , Purpura/prevention & control
20.
Dtsch Med Wochenschr ; 132(49): 2624-6, 2007 Dec.
Article in German | MEDLINE | ID: mdl-18050026

ABSTRACT

HISTORY: A 60-year-old man with diabetes mellitus and chronic renal insufficiency needing hemodialysis was admitted with a 3 months history of multiple hyperkeratotic papules on the trunk and extremities partly ulcerated with a keratotic central plug. INVESTIGATIONS: Laboratory tests revealed elevated levels of blood urea nitrogen, creatinine, and HbA (1c). Histopathology showed vertical strands of collagen perforating from the ulcerated lesions. COURSE, DIAGNOSIS AND TREATMENT: The biopsy specimen was consistent with acquired reactive perforating collagenosis. The progression was stopped and secondary wound healing was initiated after two weeks of therapy with allopurinol and PUVA. CONCLUSION: Acquired reactive perforating collagenosis should be considered when ulcera with oystershell-like keratotic plugs are found especially in patients with predisposing diseases like diabetes and renal insufficiency. A good interdisciplinary cooperation between internist and dermatologist is crucial for the early recognition by histopathology and the immediate treatment.


Subject(s)
Collagen Diseases/epidemiology , Diabetes Mellitus, Type 2/epidemiology , Kidney Failure, Chronic/epidemiology , Skin Diseases/epidemiology , Allopurinol/therapeutic use , Antimetabolites/therapeutic use , Blood Urea Nitrogen , Collagen Diseases/drug therapy , Collagen Diseases/pathology , Creatinine/blood , Diabetes Mellitus, Type 2/complications , Glycated Hemoglobin/analysis , Humans , Kidney Failure, Chronic/complications , Kidney Failure, Chronic/therapy , Male , Middle Aged , PUVA Therapy , Skin/pathology , Skin Diseases/drug therapy , Skin Diseases/pathology , Skin Ulcer/drug therapy , Skin Ulcer/epidemiology , Skin Ulcer/pathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...